市場調查報告書

自動注射設備的全球市場 - 各產品種類·各適應症·各流通管道·各地區:市場規模·佔有率·未來展望·機會分析

Auto-injectors Market, By Product Type, By Disease Indication, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

出版商 Coherent Market Insights 商品編碼 924639
出版日期 內容資訊 英文 175 Pages
商品交期: 2-3個工作天內
價格
自動注射設備的全球市場 - 各產品種類·各適應症·各流通管道·各地區:市場規模·佔有率·未來展望·機會分析 Auto-injectors Market, By Product Type, By Disease Indication, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
出版日期: 2020年01月17日內容資訊: 英文 175 Pages
簡介

本報告提供全球自動注射設備 (自動注射器)的市場相關分析,提供產品概要,及市場基本結構及促進·阻礙因素,整體市場規模預測 (過去2年·今後9年份),各產品種類·適應症 (疾病的症狀) ·各流通管道·各地區的詳細趨勢,主要企業的簡介·業績·策略計劃等調查。

第1章 分析目的·前提條件

第2章 市場概要

  • 分析概要
    • 市場定義和範圍
  • 摘要整理
  • COM (Coherent Opportunity Map:市場機會藍圖)

第3章 市場動態·規定·趨勢分析

  • 市場動態
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 影響度分析
  • 近幾年主要的動向
  • 技術進步
  • 法規方案

第4章 全球自動注射設備市場:各產品種類 (以金額為準,2017∼2027年)

  • 簡介
  • 市場佔有率:各產品種類 (2019年,2027年)
  • 與前一年同期比較成長率 (YoY):各產品種類 (2019∼2027年)
  • 各市場區隔趨勢
    • 預填充式自動注射設備
    • 填充式自動注射設備
      • 簡介
      • 市場規模與其預測,與前一年同期相比成長率 (YoY) (以金額為準,2019∼2027年)

第5章 全球自動注射設備市場:各適應症 (以金額為準,2017∼2027年)

  • 簡介
  • 市場佔有率:各適應症 (2019年,2027年)
  • 與前一年同期比較成長率 (YoY):各適應症 (2019∼2027年)
  • 市場區隔趨勢
    • 過敏性反應
    • 多發性硬化症
    • 類風濕性關節炎
    • 其他

第6章 全球自動注射設備市場:各終端用戶 (以金額為準,2017∼2027年)

  • 簡介
  • 市場佔有率:各終端用戶 (2019年,2027年)
  • 與前一年同期比較成長率 (YoY):各終端用戶 (2019∼2027年)
  • 市場區隔趨勢
    • 醫院藥局
    • 零售藥局
    • 線上藥局

第7章 全球自動注射設備市場:各地區 (以金額為準,2017∼2027年)

  • 簡介
  • 市場佔有率:各地區 (2019年,2027年)
  • 與前一年同期比較成長率 (YoY):各地區 (2019∼2027年)
  • 市場區隔趨勢
  • 北美
    • 簡介
    • 市場規模與其預測,與前一年同期相比成長率 (YoY) (以金額為準,2019∼2027年)
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 東南亞國協
    • 澳洲
    • 韓國
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 中東
    • 波灣合作理事會 (GCC) 各國
    • 以色列
    • 其他
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭環境

  • 企業簡介
  • Becton, Dickinson and Company
    • 公司概要
    • 產品系列
    • 主要的開發
    • 財務實際成果
    • 策略
  • Sanofi S.A.
  • Pfizer, Inc.
  • Mylan N.V.
  • Novartis International AG
  • Bayer AG.
  • Janssen Global Services Llc
  • Antares Pharma, Inc.
  • Eli Lilly and Co.
  • Amgen, Inc.

第9章 附錄

目錄

Auto- injector is a medical device which can deliver dose of medications. Auto injectors are easy to use and self-administration by patients is possible. Auto-injectors come under injectable drug delivery which is considered as the most effective route of administration for the effective delivery of drugs to the targeted site, which enhances the patient's compliance to the drug. The Injectable delivery enhances the rapid absorption of drug from various sites such as subcutaneous, intravenous, and intramuscular. The injectable delivery increases the bioavailability of the drug at the systemic circulation, which offers availability of drug at intended site of action. Epinephrine auto-injector is a type of auto-injector widely used for people at risk of anaphylaxis. Auto-injectors are often used in the military to protect personnel from chemical warfare agents.

Restraints of the Global Auto-Injectors Market

High cost of auto-injectors, and stringent regulatory scenario are the major factors hindering growth of the global auto-injectors market. The cost of EpiPen (2-pack) increased from US$ 100 in 2007 to US$ 608. Moreover, the cost of a generic EpiPen launched in December 2016 was 300% more than that in 2007.

Key features of the study:

  • This report provides in-depth analysis of the global auto-injectors market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global auto-injectors market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Becton, Dickinson and Company, Sanofi, Pfizer, Inc., Mylan N.V., Novartis AG, Bayer AG, Janssen Global Services, LLC, Antares Pharma, Inc., Amgen Inc., and Eli Lilly and Company.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global auto-injectors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Auto-Injectors Market, By Product Type:
    • Prefilled Auto-Injectors
    • Fillable Auto-Injectors
  • Global Auto-Injectors Market, By Disease Indication:
    • Anaphylaxis
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Others
  • Global Auto-Injectors Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Auto-Injectors Market, By Geography:
    • North America
  • By Product Type
    • Prefilled Auto-Injectors
    • Fillable Auto-Injectors
  • Disease Indication
    • Anaphylaxis
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Others
  • By End User
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Country:
    • U.S.
    • Canada
    • Europe
  • By Product Type
    • Prefilled Auto-Injectors
    • Fillable Auto-Injectors
  • Disease Indication
    • Anaphylaxis
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Others
  • By End User
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Country:
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Product Type
    • Prefilled Auto-Injectors
    • Fillable Auto-Injectors
  • Disease Indication
    • Anaphylaxis
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Others
  • By End User
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Country:
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • By Product Type
    • Prefilled Auto-Injectors
    • Fillable Auto-Injectors
  • Disease Indication
    • Anaphylaxis
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Others
  • By End User
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East:
  • By Product Type
    • Prefilled Auto-Injectors
    • Fillable Auto-Injectors
  • Disease Indication
    • Anaphylaxis
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Others
  • By End User
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Product Type
    • Prefilled Auto-Injectors
    • Fillable Auto-Injectors
  • Disease Indication
    • Anaphylaxis
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Others
  • By End User
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Country/Region:
    • Central Africa
    • South Africa
    • North Africa
  • Company Profiles
    • Becton, Dickinson and Company *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
    • Sanofi S.A.
    • Pfizer, Inc.
    • Mylan N.V.
    • Novartis International AG
    • Bayer AG
    • Janssen Global Services Llc
    • Antares Pharma, Inc.
    • Amgen Inc.
    • Eli Lilly and Co.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Disease Indication
    • Market Snippet, By Distribution Channel
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario

4. Global Auto-Injectors Market, By Product Type, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Prefilled Auto-Injectors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Fillable Auto-Injectors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends

5. Global Auto-Injectors Market, By Disease Indication, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Anaphylaxis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Multiple Sclerosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Rheumatoid Arthritis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)

6. Global Auto-Injectors Market, By End User, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)

7. Global Auto-Injectors Market, By Regions, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

    • Company Profiles
    • Becton, Dickinson and Company
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Sanofi S.A.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Pfizer, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Mylan N.V.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Novartis International AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Bayer AG.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Janssen Global Services Llc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Antares Pharma, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Eli Lilly and Co.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Amgen, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact